The Independent Voice of
European Private Equity

Advanced Search

Inflexion-backed CNX Therapeutics makes first bolt-on acquisition

Jennifer Forrest 29 July 2022

Inflexion-backed CNX Therapeutics has made its first bolt-on acquisition, via Synchrony Pharma Limited. 

Founded in 2008, Synchrony is a UK-based pharmaceutical company, specialising in the development and commercialisation of niche injectable...

Related Articles

Profile: Fondo Italiano d’Investimento celebrates raise of €1.2bn despite headwinds

08/05/24

Naxicap Partners acquires majority stake in spare parts distributor ITAL Express

08/05/24

Patrimonium and Wille Finance invest in EM

08/05/24

Montagu-backed HTL Biotechnology carves out Modern Meadow biomedical division

08/05/24

Squire Patton Boggs hires leveraged finance partner

08/05/24

Livonia Partners invests in Baltic tech firm Telema

08/05/24